RVMD - Revolution Medicines, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$215.33
DETAILS
HIGH:
$260.00
LOW:
$175.00
MEDIAN:
$217.50
CONSENSUS:
$215.33
DOWNSIDE:
0.05%
Institutional Holders (13F)
| GURU | SHARES | VALUE | WEIGHT % | SHARES CHG | ACTION |
|---|---|---|---|---|---|
| Druckenmiller | 399,587 | $74.8M | 1.4% | +83,727 | INCREASED |
| Greenblatt | 120,702 | $22.6M | 0.1% | -5,199 | DECREASED |
| Cooperman | 35,500 | $6.6M | 0.0% | +10,500 | INCREASED |
| Wood | 20,300 | $3.8M | 0.0% | +17,700 | INCREASED |
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-08-21 | Cislini Jeff | officer: General Counsel | SELL | 3,400 | $207.24 | $705K |
| 2026-08-21 | Cislini Jeff | officer: General Counsel | SELL | 25,817 | $209.25 | $5.4M |
| 2026-08-21 | Cislini Jeff | officer: General Counsel | SELL | 2,540 | $210.26 | $534K |
| 2026-08-21 | Cislini Jeff | officer: General Counsel | SELL | 4,500 | $211.34 | $951K |
| 2026-08-21 | GOLDSMITH MARK A | director, officer: See Remarks | SELL | 35,938 | $209.26 | $7.5M |
| 2026-08-21 | GOLDSMITH MARK A | director, officer: See Remarks | SELL | 3,813 | $210.25 | $802K |
| 2026-08-21 | GOLDSMITH MARK A | director, officer: See Remarks | SELL | 177 | $207.25 | $37K |
| 2026-08-21 | GOLDSMITH MARK A | director, officer: See Remarks | SELL | 190 | $207.25 | $39K |
| 2026-08-21 | GOLDSMITH MARK A | director, officer: See Remarks | SELL | 937 | $208.36 | $195K |
| 2026-08-21 | GOLDSMITH MARK A | director, officer: See Remarks | SELL | 245 | $211.47 | $52K |
| 2026-08-21 | GOLDSMITH MARK A | director, officer: See Remarks | SELL | 229 | $211.46 | $48K |
| 2026-08-21 | GOLDSMITH MARK A | director, officer: See Remarks | SELL | 127 | $212.06 | $27K |
| 2026-08-21 | GOLDSMITH MARK A | director, officer: See Remarks | SELL | 5,128 | $207.23 | $1.1M |
| 2026-08-21 | Cislini Jeff | officer: General Counsel | SELL | 3,314 | $212.06 | $703K |
| 2026-08-21 | GOLDSMITH MARK A | director, officer: See Remarks | SELL | 3,621 | $212.08 | $768K |
| 2026-08-21 | GOLDSMITH MARK A | director, officer: See Remarks | SELL | 951 | $208.36 | $198K |
| 2026-08-21 | GOLDSMITH MARK A | director, officer: See Remarks | SELL | 1,351 | $209.28 | $283K |
| 2026-08-21 | GOLDSMITH MARK A | director, officer: See Remarks | SELL | 136 | $210.40 | $29K |
| 2026-08-21 | Cislini Jeff | officer: General Counsel | SELL | 17,323 | $208.37 | $3.6M |
| 2026-08-21 | Cislini Jeff | officer: General Counsel | M-Exempt | 26,600 | $21.61 | $575K |
| 2026-08-21 | GOLDSMITH MARK A | director, officer: See Remarks | SELL | 1,405 | $209.27 | $294K |
| 2026-08-21 | GOLDSMITH MARK A | director, officer: See Remarks | SELL | 126 | $212.06 | $27K |
| 2026-08-21 | GOLDSMITH MARK A | director, officer: See Remarks | M-Exempt | 80,000 | $4.73 | $378K |
| 2026-08-21 | GOLDSMITH MARK A | director, officer: See Remarks | SELL | 24,917 | $208.37 | $5.2M |
| 2026-08-21 | GOLDSMITH MARK A | director, officer: See Remarks | SELL | 6,583 | $211.33 | $1.4M |